Via Licensing taps Xiaomi’s former IP strategy head as advisor
Paul Lin, now managing director of Eagle Forest, aims to provide the licensee’s perspective to arm Via as it navigates a shifting patent pool landscape
Paul Lin, now managing director of Eagle Forest, aims to provide the licensee’s perspective to arm Via as it navigates a shifting patent pool landscape
In retrospect, the US R&D and licensing business would surely have preferred to take a hit in order to settle its dispute with Lenovo out of sight and in secret
Parent company Quarterhill is still undergoing a strategic review to determine whether to sell WiLAN, but doesn’t want the delay to remind anyone of the stagnant BlackBerry patent sale
London judge refuses to restrain Big Blue from US IP proceedings against LzLabs
22 August 2022
The chipmaker spawned the term “patent troll” and has been highly critical of NPEs, but negative business headwinds mean that putting its world-class portfolio of IP assets to work is a no brainer
19 August 2022
In an exclusive interview, the company’s CEO Jacob Babcock details its journey to becoming a technology licensing business
16 August 2022
A strategic review that began in December 2021 is ongoing with several options being explored and meanwhile the firm continues to do deals
11 August 2022
The Asia-Pacific region’s premier event about the business of IP will take place in the Japanese capital from 31 October to 2 November
10 August 2022
The portfolio covers a wide range of the tech produced by the Silicon Valley giant and will now be monetised by an entity named Tahoe Research Limited
08 August 2022
The firm is the latest in a string of big-ticket licensors to have published their quarterly earnings, following Ericsson, Nokia and Qualcomm
05 August 2022
New amendments encompass 40 new articles, alongside revisions to 41 others. They aim to enhance protection of trade secrets and strengthen communications between the IP Court and the IP Office, among other goals.
03 August 2022
Marianne Frydenlund joins the firm from Nordic Semicondustor with a brief to develop solutions for IoT-related sectors beyond auto
01 August 2022
The French company is one of several big pharmas to have offloaded deprioritised drugs in recent months
29 July 2022
Unlock unlimited access to all IAM content